Publikationen 2001
Dissertationen
Originalarbeiten
Reviews
Buchbeiträge, Bücher
Publizierte Abstracts, Letters
Riedewald J.
Phänotypische Charakterisierung biofilmnegativer Transposonmutanten: Indentifizierung des interzellulären Polysaccharid-Adhäsins als Hämagglutinin von Staphylococcus epidermidis.
Dissertation Fachbereich Medizin. Universität Hamburg. 2001.
Bartscht K.
Adhäsion von Staphylococcus epidermidis an Oberflächen: Charakterisierung einer Biofilm-negativen Mutante.
Dissertation Fachbereich Biologie. Universität Hamburg. 2001
Christoph F, Kaulfers PM, Stahl-Biskup E.
In vitro evaluation of the antibacterial activity of beta-triketones admixed to Melaleuca oils.
Planta Med. 2001 Nov;67(8):768-71.
Christoph F, Stahl-Biskup E, Kaulfers PM.
Death kinetics of Staphylococcus aureus exposed to commercial tea tree oils.
J Essent Oil Res. 2001;13:98-102.
Dobinsky S, Mack D.
Efficient RNA isolation method for analysis of transcription in sessile Staphylococcus epidermidis biofilm cultures.
Methods Enzymol. 2001;336:255-62.
Gawad KA, Schneider C, Brinken B, Hufländer A, Diederichs B, Mack D, Gutensohn K, Izbicki JR.
Anti-TNF antibody treatment has no positive effect on survival in a model of pneumococcal sepsis in pigs.
J Invest Surg. 2001 Sep-Oct;14(5):291-7.
Gu YL, Dahmen U, Doebel L, Li J, Dirsch O, Polywka S, Broelsch CE.
Influence of CsA treatment on adoptive transfer of immunity after allogeneic kidney transplantation in rats.
Transplant Proc. 2001 Feb-Mar;33(1-2):398-400.
Horstkotte MA, Knobloch JK, Rohde H, Mack D.
Rapid detection of methicillin resistance in coagulase-negative staphylococci by a penicillin-binding protein 2a-specific latex agglutination test.
J Clin Microbiol. 2001 Oct;39(10):3700-2.
Horstkotte MA, Sobottka I, Schewe CK, Schäfer P, Laufs R, Rüsch-Gerdes S, Niemann S.
Mycobacterium microti llama-type infection presenting as pulmonary tuberculosis in a human immunodeficiency virus-positive patient.
J Clin Microbiol. 2001 Jan;39(1):406-7.
Kähler J, Gerth S, Schäfer P, Boersma E, Köster R, Terres W, Simoons ML, Berger J, Meinertz T, Hamm CW.
Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris.
Am J Cardiol. 2001 May 15;87(10):1150-3.
Knobloch JK, Bartscht K, Sabottke A, Rohde H, Feucht HH, Mack D.
Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress.
J Bacteriol. 2001 Apr;183(8):2624-33.
Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Schafhausen P, Jaburg N, Löliger C, Schäfer P, Hinke A, Zander AR.
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.
Br J Haematol. 2001 Jun;113(4):1060-71.
Laufs R, Polywka S, Buggisch P.
Hepatitis C durch Nadelstichverletzung mit Erfolg behandelt.
Hamburger Ärzteblatt. 2001;5/01:262-263.
Laufs R, Polywka S, Feucht HH, Zöllner B.
Verhaltensregeln bei berufsbedingter Exposition mit Aids- und Hepatitisviren.
Hamburger Ärzteblatt. 2001;5/01:258-261.
Mack D, Bartscht K, Fischer C, Rohde H, de Grahl C, Dobinsky S, Horstkotte MA, Kiel K, Knobloch JK.
Genetic and biochemical analysis of Staphylococcus epidermidis biofilm accumulation.
Methods Enzymol. 2001;336:215-39.
Manegold C, Hannoun C, Wywiol A, Dietrich M, Polywka S, Chiwakata CB, Günther S.
Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
Clin Infect Dis. 2001 Jan;32(1):144-8. Epub 2000 Dec 13.
Meyer T, Lemcke T, Geffken D, Kaulfers PM.
Synthesis and antibacterial activity of 5- and 6-hydroxy substituted 4-aminoquinolines and derivatives.
Pharmazie. 2001 Sep;56(9):691-5.
Polywka S, Feldner J, Duttmann H, Laufs R.
Diagnostic evaluation of a new combined HIV p24 antigen and anti-HIV1/2/O screening assay.
Clin Lab. 2001;47(7-8):351-6.
Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.
Relevance of reactivity in commercially available hepatitis C virus antibody assays.
J Clin Microbiol. 2001 Apr;39(4):1665-8.
Rohde H, Knobloch JK, Horstkotte MA, Mack D.
Correlation of biofilm expression types of Staphylococcus epidermidis with polysaccharide intercellular adhesin synthesis: evidence for involvement of icaADBC genotype-independent factors.
Med Microbiol Immunol. 2001 Dec;190(3):105-12.
Schäfer P, Tenschert W, Cremaschi L, Schröter M, Zöllner B, Laufs R.
Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients.
J Med Virol. 2001 Sep;65(1):85-9.
Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.
Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.
J Clin Microbiol. 2001 Feb;39(2):765-8.
Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.
Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis.
Nephron. 2001 Feb;87(2):139-42.
Schröter M, Schäfer P, Zöllner B, Polywka S, Laufs R, Feucht HH.
Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay.
J Med Virol. 2001 Jul;64(3):320-4.
Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.
Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays.
J Clin Virol. 2001 Dec;23(1-2):57-63.
Sobottka I, Iglauer F, Schüler T, Schmetz C, Visvesvara GS, Albrecht H, Schwartz DA, Pieniazek NJ, Bartscht K, Laufs R, Schottelius J.
Acute and long-term humoral immunity following active immunization of rabbits with inactivated spores of various Encephalitozoon species.
Parasitol Res. 2001 Jan;87(1):1-6.
van der Strate BW, Harmsen MC, Schäfer P, Swart PJ, The TH, Jahn G, Speer CP, Meijer DK, Hamprecht K.
Viral load in breast milk correlates with transmission of human cytomegalovirus to preterm neonates, but lactoferrin concentrations do not.
Clin Diagn Lab Immunol. 2001 Jul;8(4):818-21.
Weitzel T, Wolff M, Dabanch J, Levy I, Schmetz C, Visvesvara GS, Sobottka I.
Dual microsporidial infection with Encephalitozoon cuniculi and Enterocytozoon bieneusi in an HIV-positive patient.
Infection. 2001 Aug;29(4):237-9.
Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmüller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR.
Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis.
Crit Care Med. 2001 Jul;29(7):1423-30.
Zöllner B, Feucht HH, Schröter M, Schäfer P, Plettenberg A, Stoehr A, Laufs R.
Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.
AIDS. 2001 May 4;15(7):935-6.
Zöllner B, Feucht HH, Weitner L, Adam A, Schröter M, Schäfer P, Laufs R.
Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.
J Clin Virol. 2001 Apr;21(1):37-45.
Zöllner B, Petersen J, Schröter M, Laufs R, Schoder V, Feucht HH.
20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.
Lancet. 2001 Mar 24;357(9260):934-5.
Zöllner B, Schäfer P, Feucht HH, Schröter M, Petersen J, Laufs R.
Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy.
J Med Virol. 2001 Dec;65(4):659-63.
Laufs R.
Die Grundlagen der Gentechnik und ihre Anwendung bei der Enträtselung eines neuen Virus.
Der Prüfingenieur. 2001;19:18-27.
Rohde H, Baehr M, Mack D.
Im Dschungel der Antibiotika: nützliche neue und unverzichtbare alte Präparate.
Der Hausarzt. 2001;38(3):38-42.
Rohde H, Baehr M, Mack D.
Antibiotika-Einsatz in der Praxis: Die Qual der Wahl.
Der Hausarzt. 2001;38(4):49-55.
Rohde H, Mack D, Sobottka I, Speicher A, Horstkotte MA, Knobloch JK, Protzen M, Laufs R.
Arthritis nach Hüftendoprothesen-Implantation.
Hamburger Ärzteblatt. 2001;12/01:597-598.
Schäfer P, Tenschert W, Cremaschi L, Schröter M, Zöllner B, Laufs R.
Cytomegalovirus infections in kidney transplant patients: virological determinants of clinical features.
Res Adv Microbiol. 2001;2:59-66.
Bartscht K, Knobloch JK, Mack D.
Identification of a new regulatory gene locus involved in biofilm formation of Staphylococcus epidermidis 1457.
Int J Med Microbiol. 2001;291(Suppl 32):V89.
Bierhenke R, Schmage P, Nergiz I, Kaulfers PM, Famouri A, Deknock U, Platzer U.
Concept to preserve the water quality of the dental unit.
J of Dental Research. 2001;80:621. 79th IADR June 27-30, 2001 Chiba, Japan
Dobinsky S, Mack D.
The level of icaADBC transcription is not correlated to the level of biofilm-accumulation of ica-positive Staphylococcus epidermidis strains.
Int J Med Microbiol. 2001;291(Suppl 32):59.
Horstkotte MA, Knobloch JK, Rohde H, Mack D.
Detection of oxacillin resistance in coagulase-negative staphylococci using the Phoenix system.
Int J Med Microbiol. 2001;291(Suppl 32):20.
Horstkotte MA, Knobloch JK, Rohde H, Mack D.
Evaluation of the VITEK 2 system for the detection of methicillin resistance in coagulase-negative staphylococci.
Int J Med Microbiol. 2001;291(Suppl 32):21.
Kiel K, Rohde H, Knobloch JK, Mack D.
Overexpression of PIA in Staphylococcus epidermidis is inhibited by inactivation of PTS glucose permease GlcA or its regulating antiterminator GlcT.
Int J Med Microbiol. 2001;291(Suppl 32):V88.
Knobloch JK, von Osten H, Mack D.
Attached Staphylococcus epidermidis has reduced susceptibility against quinolones independent from biofilm formation.
41st ICAAC 2001, Chicago, Abstract ICAAC01-A-39289-ASM.
Knobloch JK, von Osten H, Horstkotte MA, Rohde H, Mack D.
Reduced quinolone-susceptibility of attached Staphylococcus epidermidis is independent of biofilm accumulation.
Int J Med Microbiol. 2001;291(Suppl 32):V12
Mack D.
Biofilm accumulation of Staphylococcus epidermidis: molecular mechanisms and importance for virulence.
Int J Med Microbiol. 2001;291(Suppl 32):H13.
Pforte A, Hauber HP, Mack D, Schumacher U.
Inhalation mit Fucose und Galactose als neuer Therapieansatz bei erwachsenen Mukoviszidosepatienten mit Pseudomonas aeruginosa-Infektion.
Pneumologie. 2001;55(Sonderheft 1):S68.
Polywka S, Laufs R.
Hautinfektionen bei Suchtkranken: Präsentation eines Falles einere nekrotisierenden Fasziitis.
Suchttherapie. 2001(Suppl 1):48-9.
Polywka S, Laufs R.
Lack of specificity in commercially available screening assays for hepatitis C virus antibodies.
Infus Ther Transfus Med. 2001;(Suppl 1):46.
Rohde H, Bartscht K, Kiel K, Knobloch JK, Mack D.
Identification of a new polysaccharide intercellular adhesin independent mechanism of Staphylococcus epidermidis biofilm formation.
Int J Med Microbiol. 2001;291(Suppl 32):63.
Rohde H, Knobloch JK, Horstkotte MA, Mack D.
Correlation of Staphylococcus aureus icaADBC Genotype and Biofilm Expression Phenotype
J Clin Microbiol. 2001;39:4595-6.
Schäfer P, Tenschert W, Cremaschi L, Schröter M, Zöllner B, Laufs R.
Area under the curve: A new approach to predicting symptomatic cytomegalovirus infections.
8th International Cytomegalovirus Workshop, Asilomar, CA, USA, 20.-25.5.2001. Poster Nr. 17T
Schäfer P, Tenschert W, Cremaschi L, Schröter M, Zöllner B, Laufs R.
Ein neues Konzept zur Vorhersage symptomatischer Cytomegalovirus-Infektionen bei Patienten nach Nierentransplantation.
Jahrestagung der Gesellschaft für Virologie, Dresden, 14.-17.3.2001. Vortrag Nr. 3
Schumacher U, Adam EC, Schneppenheim R, Hauber HP, Mack D, Pforte A.
Treatment of Pseudomonas aeruginosa infection by a sugar solution: A story from bench to bedside.
Ann Anat. 2001;(Suppl 96 Verhandlung der Anatomischen Gesellschaft):12-13.
Stürenburg E, Sobottka I, Mack D, Laufs R.
Cloning and sequnecing of Enterobacter aerogenes OmpC-type osmoporin mediating carbapenem resistance.
Int J Med Microbiol. 2001;291(Suppl 32):160.
 |
Links |
